Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC).
Publication
, Conference
Hoffe, S; Frakes, JM; Aguilera, TA; Czito, B; Palta, M; Brookes, M; Schweizer, C; Colbert, L; Moningi, S; Bhutani, MS; Pant, S; Tzeng, CW ...
Published in: Int J Radiat Oncol Biol Phys
December 1, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Int J Radiat Oncol Biol Phys
DOI
EISSN
1879-355X
Publication Date
December 1, 2020
Volume
108
Issue
5
Start / End Page
1399 / 1400
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hoffe, S., Frakes, J. M., Aguilera, T. A., Czito, B., Palta, M., Brookes, M., … Taniguchi, C. M. (2020). Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC). In Int J Radiat Oncol Biol Phys (Vol. 108, pp. 1399–1400). United States. https://doi.org/10.1016/j.ijrobp.2020.09.022
Hoffe, S., J. M. Frakes, T. A. Aguilera, B. Czito, M. Palta, M. Brookes, C. Schweizer, et al. “Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC).” In Int J Radiat Oncol Biol Phys, 108:1399–1400, 2020. https://doi.org/10.1016/j.ijrobp.2020.09.022.
Hoffe S, Frakes JM, Aguilera TA, Czito B, Palta M, Brookes M, et al. Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC). In: Int J Radiat Oncol Biol Phys. 2020. p. 1399–400.
Hoffe, S., et al. “Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC).” Int J Radiat Oncol Biol Phys, vol. 108, no. 5, 2020, pp. 1399–400. Pubmed, doi:10.1016/j.ijrobp.2020.09.022.
Hoffe S, Frakes JM, Aguilera TA, Czito B, Palta M, Brookes M, Schweizer C, Colbert L, Moningi S, Bhutani MS, Pant S, Tzeng CW, Tidwell RS, Thall P, Yuan Y, Moser EC, Holmlund J, Herman J, Taniguchi CM. Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (PC). Int J Radiat Oncol Biol Phys. 2020. p. 1399–1400.
Published In
Int J Radiat Oncol Biol Phys
DOI
EISSN
1879-355X
Publication Date
December 1, 2020
Volume
108
Issue
5
Start / End Page
1399 / 1400
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 0299 Other Physical Sciences